Bristol Myers Squibb (BMY)

EBITDA Growth

55.61%

Quarterly · Period ending:

BMY logo

BMY EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported55.61%
BMY Quarterly EBITDA YoY % (12.04% → 55.61%)
High-resolution chart · PNG

BMY ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb EBITDA Growth — Quarterly
Period endingEBITDA Growth
-1.7804%
4.5428%
3.5838%
14.2667%
13.6977%
4.504%
16.3416%
-0.1332%
13.1298%
13.5453%
18.1096%
12.4251%
12.2536%
14.2068%
15.8234%
12.6476%
11.5679%
9.8873%
3.327%
13.4928%
10.3376%
13.2613%
26.1391%
9.3096%
11.2676%
12.1145%
373.8636%
6.3404%
8.9514%
6.3232%
193.617%
1.812%
5.6757%
4.1463%
-129.421%
4.0047%
-0.6711%
5.2632%
19.6629%
9.4072%
11.8619%
18.5693%
109.2934%
-66.5517%
-70.3209%
-70.9934%
-23.7295%
5.6466%
6.8063%
6.991%
-10.532%
16.2212%
11.1934%
12.0402%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.